Literature DB >> 18845838

High-dose intrathecal trastuzumab for leptomeningeal metastases secondary to HER-2 overexpressing breast cancer.

O Mir, S Ropert, J Alexandre, F Lemare, F Goldwasser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18845838     DOI: 10.1093/annonc/mdn654

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  30 in total

Review 1.  Therapeutic approaches for HER2-positive brain metastases: circumventing the blood-brain barrier.

Authors:  Ankit I Mehta; Adam M Brufsky; John H Sampson
Journal:  Cancer Treat Rev       Date:  2012-06-22       Impact factor: 12.111

Review 2.  Systemic Therapy for HER2-Positive Central Nervous System Disease: Where We Are and Where Do We Go From Here?

Authors:  Eleonora Teplinsky; Francisco J Esteva
Journal:  Curr Oncol Rep       Date:  2015-10       Impact factor: 5.075

3.  Meningeal carcinomatosis in HER2-overexpressing breast cancers.

Authors:  F C Bidard; M N Guilhaume; H Gauthier; P H Cottu; V Diéras; J Y Pierga
Journal:  J Neurooncol       Date:  2009-01-13       Impact factor: 4.130

Review 4.  Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials.

Authors:  Marc Chamberlain; Riccardo Soffietti; Jeffrey Raizer; Roberta Rudà; Dieta Brandsma; Willem Boogerd; Sophie Taillibert; Morris D Groves; Emilie Le Rhun; Larry Junck; Martin van den Bent; Patrick Y Wen; Kurt A Jaeckle
Journal:  Neuro Oncol       Date:  2014-05-27       Impact factor: 12.300

Review 5.  Breast leptomeningeal disease: a review of current practices and updates on management.

Authors:  Nicholas B Figura; Victoria T Rizk; Avan J Armaghani; John A Arrington; Arnold B Etame; Hyo S Han; Brian J Czerniecki; Peter A Forsyth; Kamran A Ahmed
Journal:  Breast Cancer Res Treat       Date:  2019-06-17       Impact factor: 4.872

6.  Fatal herpetic encephalitis during brain radiotherapy in a cerebral metastasized breast cancer patient.

Authors:  Tatiana Koudriavtseva; Emanuela Onesti; Riccardo Tonachella; Lorella Pelagalli; Antonello Vidiri; Bruno Jandolo
Journal:  J Neurooncol       Date:  2010-02-11       Impact factor: 4.130

Review 7.  Current Treatment Options for Breast Cancer Brain Metastases.

Authors:  Arrvind Raghunath; Kunal Desai; Manmeet S Ahluwalia
Journal:  Curr Treat Options Oncol       Date:  2019-02-15

8.  Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment.

Authors:  Ticiana Leal; Julie E Chang; Minesh Mehta; H Ian Robins
Journal:  Curr Cancer Ther Rev       Date:  2011-11

Review 9.  PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer.

Authors:  Parvin F Peddi; Sara A Hurvitz
Journal:  J Neurooncol       Date:  2014-01-28       Impact factor: 4.130

10.  Complement activation and intraventricular rituximab distribution in recurrent central nervous system lymphoma.

Authors:  Cigall Kadoch; Jing Li; Valerie S Wong; Lingjing Chen; Soonmee Cha; Pamela Munster; Clifford A Lowell; Marc A Shuman; James L Rubenstein
Journal:  Clin Cancer Res       Date:  2013-11-04       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.